
Autologous transplantation of cytokine-induced killer cells as an adjuvant therapy for hepatocellular carcinoma in Asia: an update meta-analysis and systematic review
Author(s) -
XiuRong Cai,
Xing Li,
Jieqiong Lin,
Tiantian Wang,
Min Dong,
Zhan-Hong Chen,
Changchang Jia,
YingFen Hong,
Lin Q,
Xiang-yuan Wu
Publication year - 2017
Publication title -
oncotarget
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.373
H-Index - 127
ISSN - 1949-2553
DOI - 10.18632/oncotarget.15454
Subject(s) - hepatocellular carcinoma , medicine , adjuvant , meta analysis , transplantation , carcinoma , cytokine , immunology , adjuvant therapy , liver transplantation , oncology , cancer research , cancer
High recurrence rate after curative treatment is the major problem for hepatocellular carcinoma (HCC). Cytokine-induced killer cells (CIKs) therapy was extensively studied among HCC patients. However, the value of CIKs therapy was controversial. A meta-analysis was performed to investigate the efficacy of adjuvant CIKs after invasive treatments among HCC patients.